Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigil Haroon

Showing results (111-120 of 149) with videos related to

Pageof 15
Sort By:
Arthritis Care & Research|July 16, 2021
Bridging the Gap Between Symptom Onset and Diagnosis in Axial SpondyloarthritisLaura Passalent, Kala Sundararajan, Anthony V Perruccio, et al.
Annals of the Rheumatic Diseases|February 7, 2025
Impact of clinical subtype and sex on first-line biologic therapy discontinuation in axial spondyloarthritisPatricia Remalante-Rayco, Emmanuel S Baja, Zeynep Baskurt, et al.
The Journal of Rheumatology|October 24, 2024
Prologue: Spondyloarthritis Unmet Research Needs Conference IVRobert A Colbert, Ellen Carroll, Maureen Dubreuil, et al.
Endocrine|August 14, 2024
Finerenone and diabetic renal disease: a narrative reviewKirthika Venkatesan, Mabel Mary James Cheryeth, Anna Tintu Verghese, et al.
Rheumatology (Oxford, England)|October 4, 2023
Incidence and predictors of demyelinating disease in spondyloarthritis: data from a longitudinal cohort studyPatricia Remalante-Rayco, Adrian I Espiritu, Yassir Daghistani, et al.
The Journal of Rheumatology|May 3, 2019
Advancing Early Identification of Axial Spondyloarthritis: An Interobserver Comparison of Extended Role Practitioners and RheumatologistsLaura Passalent, Christopher Hawke, Daeria O Lawson, et al.
ACR Open Rheumatology|July 14, 2022
Minimal Impact of the COVID-19 Pandemic on Disease Activity and Health-Related Quality of Life in Patients With Ankylosing Spondylitis Receiving Bimekizumab: Exploratory Analyses From a Phase 2b Open-Label Extension StudyPhilip C Robinson, Pedro M Machado, Nigil Haroon, et al.
Arthritis Research & Therapy|October 14, 2011
Aberrant axial mineralization precedes spinal ankylosis: a molecular imaging study in ank/ank miceFacundo Las Heras, Ralph S DaCosta, Kenneth P H Pritzker, et al.
Annals of the Rheumatic Diseases|May 10, 2015
Private rare deletions in SEC16A and MAMDC4 may represent novel pathogenic variants in familial axial spondyloarthritisDarren D O'Rielly, Mohammed Uddin, Dianne Codner, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 9, 2019
A Fifty-Two-Week, Randomized, Placebo-Controlled Trial of Certolizumab Pegol in Nonradiographic Axial SpondyloarthritisAtul Deodhar, Lianne S Gensler, Jonathan Kay, et al.
Pageof 15

Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
Arthritis Care & Research|July 16, 2021
Bridging the Gap Between Symptom Onset and Diagnosis in Axial SpondyloarthritisLaura Passalent, Kala Sundararajan, Anthony V Perruccio, et al.
Annals of the Rheumatic Diseases|February 7, 2025
Impact of clinical subtype and sex on first-line biologic therapy discontinuation in axial spondyloarthritisPatricia Remalante-Rayco, Emmanuel S Baja, Zeynep Baskurt, et al.
The Journal of Rheumatology|October 24, 2024
Prologue: Spondyloarthritis Unmet Research Needs Conference IVRobert A Colbert, Ellen Carroll, Maureen Dubreuil, et al.
Endocrine|August 14, 2024
Finerenone and diabetic renal disease: a narrative reviewKirthika Venkatesan, Mabel Mary James Cheryeth, Anna Tintu Verghese, et al.
Rheumatology (Oxford, England)|October 4, 2023
Incidence and predictors of demyelinating disease in spondyloarthritis: data from a longitudinal cohort studyPatricia Remalante-Rayco, Adrian I Espiritu, Yassir Daghistani, et al.
The Journal of Rheumatology|May 3, 2019
Advancing Early Identification of Axial Spondyloarthritis: An Interobserver Comparison of Extended Role Practitioners and RheumatologistsLaura Passalent, Christopher Hawke, Daeria O Lawson, et al.
ACR Open Rheumatology|July 14, 2022
Minimal Impact of the COVID-19 Pandemic on Disease Activity and Health-Related Quality of Life in Patients With Ankylosing Spondylitis Receiving Bimekizumab: Exploratory Analyses From a Phase 2b Open-Label Extension StudyPhilip C Robinson, Pedro M Machado, Nigil Haroon, et al.
Arthritis Research & Therapy|October 14, 2011
Aberrant axial mineralization precedes spinal ankylosis: a molecular imaging study in ank/ank miceFacundo Las Heras, Ralph S DaCosta, Kenneth P H Pritzker, et al.
Annals of the Rheumatic Diseases|May 10, 2015
Private rare deletions in SEC16A and MAMDC4 may represent novel pathogenic variants in familial axial spondyloarthritisDarren D O'Rielly, Mohammed Uddin, Dianne Codner, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 9, 2019
A Fifty-Two-Week, Randomized, Placebo-Controlled Trial of Certolizumab Pegol in Nonradiographic Axial SpondyloarthritisAtul Deodhar, Lianne S Gensler, Jonathan Kay, et al.
Pageof 15